That is what grabbed me. Revenues from MuGard are just that. They can help fund the clinicals for SDF. It seems those clinicals can be wrapped up in a short time , one year, two tops. Once approved I don't know if they will license the technology or just go it alone. The Scientific Board that they have recently put together have almost 100 years of experience in this field. I think they go it alone and reap all of the possible revenues. 40 could be very conservative. But I will take it. Hopefully I will at least doubled my position before than if my other investments work to my favor.